Dongguan, China

Kangzhi Ye

This inventor holds 1 USPTO granted patent and 4 published patent applications and 1 EPO patent. Top assignee: Sunshine Lake Pharma Co., Ltd.. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kangzhi Ye. Retrieved from https://idiyas.com/inventor/kangzhi-ye

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 17.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kangzhi Ye - Innovator in Pharmaceutical Chemistry

Introduction

Kangzhi Ye is a notable inventor based in Dongguan, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on hexahydropentaleno derivatives.

Latest Patents

Kangzhi Ye holds a patent for "Hexahydropentaleno derivatives, preparation method and use in medicine thereof." This invention relates to hexahydropentaleno derivatives, their preparation methods, and their applications in medicine. Specifically, it focuses on these derivatives or their stereo-isomers or pharmaceutically acceptable salts, which are utilized as therapeutic agents, especially as DPP-IV inhibitors.

Career Highlights

Kangzhi Ye is associated with Sunshine Lake Pharma Co., Ltd., where he has been instrumental in advancing pharmaceutical research and development. His work has led to innovative solutions in the treatment of various medical conditions.

Collaborations

Kangzhi Ye collaborates with esteemed colleagues, including Zheng Gu and Guanpeng Qiu, to further enhance the impact of their research in the pharmaceutical industry.

Conclusion

Kangzhi Ye's contributions to pharmaceutical chemistry exemplify the importance of innovation in medicine. His work on hexahydropentaleno derivatives showcases his commitment to advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…